Home
>
National Drug Code (NDC)
>
ABRAXANE
ABRAXANE - 68817-134-50 - (Paclitaxel)
Drug Information of ABRAXANE
| Product NDC: | 68817-134 |
| Proprietary Name: | ABRAXANE |
| Non Proprietary Name: | Paclitaxel |
| Active Ingredient(s): | 100 mg/20mL & nbsp; Paclitaxel |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ABRAXANE
| Product NDC: | 68817-134 |
| Labeler Name: | Abraxis BioScience, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021660 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20050210 |
Package Information of ABRAXANE
| Package NDC: | 68817-134-50 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (68817-134-50) > 20 mL in 1 VIAL, SINGLE-USE |
NDC Information of ABRAXANE
| NDC Code | 68817-134-50 |
| Proprietary Name | ABRAXANE |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (68817-134-50) > 20 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 68817-134 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Paclitaxel |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20050210 |
| Marketing Category Name | NDA |
| Labeler Name | Abraxis BioScience, LLC |
| Substance Name | PACLITAXEL |
| Strength Number | 100 |
| Strength Unit | mg/20mL |
| Pharmaceutical Classes | Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] |
